Chitosan from Crabs (<i>Scylla serrata</i>) Represses Hyperlipidemia-Induced Hepato-Renal Dysfunctions in Rats: Modulation of CD43 and p53 Expression

Hepato-renal dysfunctions associated with hyperlipidemia necessitates a continuous search for natural remedies. This study thus evaluated the effect of dietary chitosan on diet-induced hyperlipidemia in rats. A total of 30 male Wistar rats (90 ± 10) g were randomly allotted into six (6) groups (<...

Full description

Bibliographic Details
Main Authors: Regina Ngozi Ugbaja, Kunle Ogungbemi, Adewale Segun James, Ayodele Peter Folorunsho, Samuel Olanrewaju Abolade, Stella Onajite Ajamikoko, Eniola Olapeju Atayese, Omowunmi Victoria Adedeji
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Pathophysiology
Subjects:
Online Access:https://www.mdpi.com/1873-149X/28/2/15
_version_ 1797520664816517120
author Regina Ngozi Ugbaja
Kunle Ogungbemi
Adewale Segun James
Ayodele Peter Folorunsho
Samuel Olanrewaju Abolade
Stella Onajite Ajamikoko
Eniola Olapeju Atayese
Omowunmi Victoria Adedeji
author_facet Regina Ngozi Ugbaja
Kunle Ogungbemi
Adewale Segun James
Ayodele Peter Folorunsho
Samuel Olanrewaju Abolade
Stella Onajite Ajamikoko
Eniola Olapeju Atayese
Omowunmi Victoria Adedeji
author_sort Regina Ngozi Ugbaja
collection DOAJ
description Hepato-renal dysfunctions associated with hyperlipidemia necessitates a continuous search for natural remedies. This study thus evaluated the effect of dietary chitosan on diet-induced hyperlipidemia in rats. A total of 30 male Wistar rats (90 ± 10) g were randomly allotted into six (6) groups (<i>n</i> = 5): Normal diet, High-fat diet (HFD), and Normal diet + 5% chitosan. The three other groups received HFD, supplemented with 1%, 3%, and 5% of chitosan. The feeding lasted for 6 weeks, after which the rats were sacrificed. The liver and kidneys were harvested for analyses. Hepatic alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) activity, and renal biomarkers (ALT, AST, urea, and creatinine) were assayed spectrophotometrically. Additionally, expression of hepatic and renal CD43 and p53 was estimated immunohistochemically. The HFD group had elevated bodyweight compared to normal which was reversed in the chitosan-supplemented groups. Hyperlipidemia caused a significant (<i>p</i> < 0.05) decrease in the hepatic (AST, ALT, and ALP) and renal (AST and ALT) activities, while renal urea and creatinine increased. Furthermore, the HFD group showed an elevated level of hepatic and renal CD43 while p53 expression decreased. However, groups supplemented with chitosan showed improved hepatic and renal biomarkers, as well as corrected the aberrations in the expressions of p53 and CD43. Conclusively, dietary chitosan inclusion in the diet (between 3% and 5%) could effectively improve kidney and liver functionality via abatement of inflammatory responses.
first_indexed 2024-03-10T07:59:50Z
format Article
id doaj.art-2eab2bb9a9014d3ba17a41fc47de8ca8
institution Directory Open Access Journal
issn 1873-149X
language English
last_indexed 2024-03-10T07:59:50Z
publishDate 2021-05-01
publisher MDPI AG
record_format Article
series Pathophysiology
spelling doaj.art-2eab2bb9a9014d3ba17a41fc47de8ca82023-11-22T11:31:59ZengMDPI AGPathophysiology1873-149X2021-05-0128222423710.3390/pathophysiology28020015Chitosan from Crabs (<i>Scylla serrata</i>) Represses Hyperlipidemia-Induced Hepato-Renal Dysfunctions in Rats: Modulation of CD43 and p53 ExpressionRegina Ngozi Ugbaja0Kunle Ogungbemi1Adewale Segun James2Ayodele Peter Folorunsho3Samuel Olanrewaju Abolade4Stella Onajite Ajamikoko5Eniola Olapeju Atayese6Omowunmi Victoria Adedeji7Department of Biochemistry, College of Bioscience, Federal University of Agriculture, P.M.B. 2240 Abeokuta, NigeriaDepartment of Biochemistry, College of Bioscience, Federal University of Agriculture, P.M.B. 2240 Abeokuta, NigeriaDepartment of Biochemistry, College of Bioscience, Federal University of Agriculture, P.M.B. 2240 Abeokuta, NigeriaDepartment of Biochemistry, College of Bioscience, Federal University of Agriculture, P.M.B. 2240 Abeokuta, NigeriaDepartment of Biochemistry, College of Bioscience, Federal University of Agriculture, P.M.B. 2240 Abeokuta, NigeriaDepartment of Biochemistry, College of Bioscience, Federal University of Agriculture, P.M.B. 2240 Abeokuta, NigeriaDepartment of Biochemistry, College of Bioscience, Federal University of Agriculture, P.M.B. 2240 Abeokuta, NigeriaDepartment of Biochemistry, College of Bioscience, Federal University of Agriculture, P.M.B. 2240 Abeokuta, NigeriaHepato-renal dysfunctions associated with hyperlipidemia necessitates a continuous search for natural remedies. This study thus evaluated the effect of dietary chitosan on diet-induced hyperlipidemia in rats. A total of 30 male Wistar rats (90 ± 10) g were randomly allotted into six (6) groups (<i>n</i> = 5): Normal diet, High-fat diet (HFD), and Normal diet + 5% chitosan. The three other groups received HFD, supplemented with 1%, 3%, and 5% of chitosan. The feeding lasted for 6 weeks, after which the rats were sacrificed. The liver and kidneys were harvested for analyses. Hepatic alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) activity, and renal biomarkers (ALT, AST, urea, and creatinine) were assayed spectrophotometrically. Additionally, expression of hepatic and renal CD43 and p53 was estimated immunohistochemically. The HFD group had elevated bodyweight compared to normal which was reversed in the chitosan-supplemented groups. Hyperlipidemia caused a significant (<i>p</i> < 0.05) decrease in the hepatic (AST, ALT, and ALP) and renal (AST and ALT) activities, while renal urea and creatinine increased. Furthermore, the HFD group showed an elevated level of hepatic and renal CD43 while p53 expression decreased. However, groups supplemented with chitosan showed improved hepatic and renal biomarkers, as well as corrected the aberrations in the expressions of p53 and CD43. Conclusively, dietary chitosan inclusion in the diet (between 3% and 5%) could effectively improve kidney and liver functionality via abatement of inflammatory responses.https://www.mdpi.com/1873-149X/28/2/15chitosanhyperlipidemiahigh-fat dietp53 and CD43 genesfunctional indices
spellingShingle Regina Ngozi Ugbaja
Kunle Ogungbemi
Adewale Segun James
Ayodele Peter Folorunsho
Samuel Olanrewaju Abolade
Stella Onajite Ajamikoko
Eniola Olapeju Atayese
Omowunmi Victoria Adedeji
Chitosan from Crabs (<i>Scylla serrata</i>) Represses Hyperlipidemia-Induced Hepato-Renal Dysfunctions in Rats: Modulation of CD43 and p53 Expression
Pathophysiology
chitosan
hyperlipidemia
high-fat diet
p53 and CD43 genes
functional indices
title Chitosan from Crabs (<i>Scylla serrata</i>) Represses Hyperlipidemia-Induced Hepato-Renal Dysfunctions in Rats: Modulation of CD43 and p53 Expression
title_full Chitosan from Crabs (<i>Scylla serrata</i>) Represses Hyperlipidemia-Induced Hepato-Renal Dysfunctions in Rats: Modulation of CD43 and p53 Expression
title_fullStr Chitosan from Crabs (<i>Scylla serrata</i>) Represses Hyperlipidemia-Induced Hepato-Renal Dysfunctions in Rats: Modulation of CD43 and p53 Expression
title_full_unstemmed Chitosan from Crabs (<i>Scylla serrata</i>) Represses Hyperlipidemia-Induced Hepato-Renal Dysfunctions in Rats: Modulation of CD43 and p53 Expression
title_short Chitosan from Crabs (<i>Scylla serrata</i>) Represses Hyperlipidemia-Induced Hepato-Renal Dysfunctions in Rats: Modulation of CD43 and p53 Expression
title_sort chitosan from crabs i scylla serrata i represses hyperlipidemia induced hepato renal dysfunctions in rats modulation of cd43 and p53 expression
topic chitosan
hyperlipidemia
high-fat diet
p53 and CD43 genes
functional indices
url https://www.mdpi.com/1873-149X/28/2/15
work_keys_str_mv AT reginangoziugbaja chitosanfromcrabsiscyllaserratairepresseshyperlipidemiainducedhepatorenaldysfunctionsinratsmodulationofcd43andp53expression
AT kunleogungbemi chitosanfromcrabsiscyllaserratairepresseshyperlipidemiainducedhepatorenaldysfunctionsinratsmodulationofcd43andp53expression
AT adewalesegunjames chitosanfromcrabsiscyllaserratairepresseshyperlipidemiainducedhepatorenaldysfunctionsinratsmodulationofcd43andp53expression
AT ayodelepeterfolorunsho chitosanfromcrabsiscyllaserratairepresseshyperlipidemiainducedhepatorenaldysfunctionsinratsmodulationofcd43andp53expression
AT samuelolanrewajuabolade chitosanfromcrabsiscyllaserratairepresseshyperlipidemiainducedhepatorenaldysfunctionsinratsmodulationofcd43andp53expression
AT stellaonajiteajamikoko chitosanfromcrabsiscyllaserratairepresseshyperlipidemiainducedhepatorenaldysfunctionsinratsmodulationofcd43andp53expression
AT eniolaolapejuatayese chitosanfromcrabsiscyllaserratairepresseshyperlipidemiainducedhepatorenaldysfunctionsinratsmodulationofcd43andp53expression
AT omowunmivictoriaadedeji chitosanfromcrabsiscyllaserratairepresseshyperlipidemiainducedhepatorenaldysfunctionsinratsmodulationofcd43andp53expression